氧化应激在放射性肺纤维化中的作用及中药防治研究进展
李展鸿1 徐希科2 陈威2 辛佳芸3 王金鑫2 田赛赛2 祖先鹏2 王淑美1
1.广东药科大学药学院,广东广州 510640;
2.海军军医大学药学院,上海 200433;
3.山东中医药大学药学院,山东济南 250355
Research progress of the role of oxidative stress in radiation-induced lung fibrosis and the prevention and treatment with traditional Chinese medicine
LI Zhanhong1 XU Xike2 CHEN Wei2 XIN Jiayun3 WANG Jinxin2 TIAN Saisai2 ZU Xianpeng2 WANG Shumei1
1.School of Pharmacy, Guangdong Pharmaceutical University, Guangdong Province, Guangzhou 510640, China;
2.School of Pharmacy, Naval Medical University, Shanghai 200433, China;
3.School of Pharmacy, Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250355, China
摘要 放射性肺纤维化(RILF)是临床胸部肿瘤患者放疗后发生的常见并发症,伴有咳嗽、呼吸衰竭等症状,危及患者生命。大量证据表明,电离辐射引发的氧化应激效应与RILF的发生发展密切相关,氧化应激的初始产物活性氧(ROS)贯穿整个RILF的发病过程,对RILF具有直接促进作用。本文总结了ROS在DNA损伤、炎症反应、自噬、上皮-间充质转化、细胞外基质沉积等RILF病理进展中发挥的重要作用,并概述了中药及其有效成分通过抗氧化等机制治疗RILF的研究进展,旨在为中医药防治RILF提供思路与理论支持。
关键词 :
放射性肺纤维化 ,
氧化应激 ,
活性氧 ,
中药 ,
细胞因子 ,
信号通路
Abstract :Radiation-induced lung fibrosis (RILF) is the major clinical complication of radiotherapy for thoracic tumor, seriously endangering the lives of patients. A large amount of evidence shows that the oxidative stress induced by ionizing radiation is closely related to the occurrence and development of RILF. Reactive oxygen species (ROS), the initial product of oxidative stress, runs throughout the pathogenesis of RILF, and has a direct promoting effect on RILF. This paper summarizes the important role of ROS in the pathological progression of RILF, including DNA damage, inflammation, autophagy, epithelio-mesymal transformation, and extracellular matrix deposition, and summarizes the research progress of traditional Chinese medicine and its active ingredients in the treatment of RILF through antioxidant mechanisms, aiming to provide ideas and theoretical support for the prevention, and treatment of RILF by traditional Chinese medicine.
Key words :
Radiation-induced lung fibrosis
Oxidative stress
Reactive oxygen species
Traditional Chinese medicine
Cytokine
Signaling pathway
基金资助: 国家自然科学基金资助项目(82004215);
上海市卫生健康委员会科研课题计划项目(20204Y0326);
海军军医大学“深蓝”工程“启航”人才计划项目。
通讯作者:
祖先鹏(1989.4-),男,博士,副教授;研究方向:中药药效物质基础与系统生物学。
王淑美(1966.11-),女,博士,教授;研究方向:中药质量控制。
作者简介 : 李展鸿(1998.6-),男,硕士;研究方向:中药药效物质基础与作用机制。
[1] Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer:pulmonary function,prediction,and prevention [J]. Int J Radiat Oncol Biol Phys,2005,63(1):5-24.
[2] Almeida C,Nagarajan D,Tian J,et al. The role of alveolar epithelium in radiation-induced lung injury [J]. PLoS One,2013,8(1):e53628.
[3] Rubin P, Johnston CJ,Williams JP,et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis [J]. Int J Radiat Oncol Biol Phys,1995,33(1):99-109.
[4] Sies H,Cadenas E. Oxidative stress:damage to intact cells and organs [J]. Philos Trans R Soc Lond B Biol Sci,1985, 311(1152):617-631.
[5] Daniil ZD,Papageorgiou E,Koutsokera A,et al. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis [J]. Pulm Pharmacol Ther,2008, 21(1):26-31.
[6] Veith C,Drent M,Bast A,et al. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin [J]. Toxicol Appl Pharmacol,2017,336:40-48.
[7] Lenz AG,Hinze-Heyn H,Schneider A,et al. Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases [J]. Respir Med,2004,98(8):737-745.
[8] Kinnula VL,Hodgson UA,Lakari EK,et al. Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia [J]. Histopathology,2006,49(1):66-74.
[9] Choi SH,Kim M,Lee HJ,et al. Effects of NOX1 on fibroblastic changes of endothelial cells in radiation-induced pulmonary fibrosis [J]. Mol Med Rep,2016,13(5):4135-4142.
[10] Chen C,Yang S,Zhang M,et al. Triptolide mitigates radiation-induced pulmonary fibrosis via inhibition of axis of alveolar macrophages-NOXes-ROS-myofibroblasts [J]. Ca- ncer Biol Ther,2016,17(4):381-389.
[11] Chipuk JE,Green DR. Dissecting p53-dependent apoptosis [J]. Cell Death Differ,2006,13(6):994-1002.
[12] Zhang X,Hadley C,Jackson IL,et al. Hypo-CpG methylation controls PTEN expression and cell apoptosis in irradiated lung [J]. Free Radic Res,2016,50(8):875-886.
[13] Park SH,Kim JY,Kim JM,et al. PM014 attenuates radiation-induced pulmonary fibrosis via regulating NF-κB and TGF-b1/NOX4 pathways [J]. Sci Rep,2020,10(1):16112.
[14] Ask K,Bonniaud P,Maass K,et al. Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF- beta3 [J]. Int J Biochem Cell Biol,2008,40(3):484-495.
[15] Hecker L,Vittal R,Jones T,et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury [J]. Nat Med,2009,15(9):1077-1081.
[16] Cao Q,Mak KM,Lieber CS. DLPC decreases TGF-beta1- induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells [J]. Am J Physiol Gastrointest Liver Physiol,2002,283(5):G1051-G1061.
[17] Liu RM. Oxidative stress,plasminogen activator inhibitor 1,and lung fibrosis [J]. Antioxid Redox Signal,2008,10(2):303-319.
[18] Vayalil PK,Iles KE,Choi J,et al. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1,SP-1,and Smad to the PAI-1 promoter [J]. Am J Physiol Lung Cell Mol Physiol,2007,293(5):L1281-1292.
[19] Zhang L,Wang Y,Wu G,et al. Macrophages:friend or foe in idiopathic pulmonary fibrosis?[J]. Respir Res,2018,19(1):170.
[20] Wynn TA,Barron L. Macrophages:master regulators of inflammation and fibrosis [J]. Semin Liver Dis,2010,30(3):245-257.
[21] Yao Y,Wang Y,Zhang Z,et al. Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production [J]. Mol Ther,2016, 24(5):915-925.
[22] Kobayashi K,Araya J,Minagawa S,et al. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis [J]. J Immunol,2016,197(2):504-516.
[23] Filomeni G,De Zio D,Cecconi F. Oxidative stress and autophagy:the clash between damage and metabolic needs [J]. Cell Death Differ,2015,22(3):377-388.
[24] Cao K,Lei X,Liu H,et al. Polydatin alleviated radiation-induced lung injury through activation of Sirt3 and inhibition of epithelial-mesenchymal transition [J]. J Cell Mol Med,2017,21(12):3264-3276.
[25] 林白桦,袁国荣,贾勇士,等.黄芪多糖对放射性肺损伤小鼠模型的TGF-β1、SOD的影响[J].中华中医药学刊,2015,33(6):1411-1413.
[26] 武振华.黄芪甲苷(AST-Ⅳ)对小鼠肺12C6+辐照损伤的防护效应及作用机理[D].兰州:兰州大学,2013.
[27] Lu J,Zhong Y,Lin Z,et al. Baicalin alleviates radiation-induced epithelial-mesenchymal transition of primary type Ⅱ alveolar epithelial cells via TGF-β and ERK/GSK3β signaling pathways [J]. Biomed Pharmacother,2017,95:1219- 1224.
[28] 陈银.汉防己甲素防治放射性肺纤维化的实验研究[D].南京:南京中医药大学,2017.
[29] 李广虎,李志平,徐泳,等.丹参酮ⅡA对放射性肺纤维化防治作用的实验研究[J].中华放射肿瘤学杂志,2006(1):50-54.
[30] 王文龙,林胜友,卢宏达,等.氧化苦参碱对放射性肺损伤模型小鼠肺纤维化的改善作用及其机制研究[J].中国临床药理学杂志,2020,36(5):503-506.
[31] 董广通,张知云,祁鑫,等.养阴清肺方调控放射性肺炎大鼠外周血T细胞Notch1、Jagged1信号通路[J].中国实验方剂学杂志,2017,23(24):121-127.
[32] 董广通,李铮,祁鑫,等.养阴清肺活血方对放射性肺纤维化大鼠外周血Th17/Treg平衡的影响研究[J].中国新药杂志,2017,26(24):2964-2969.
[33] 胡彦辉,于卫江,耿良,等.痰热清注射液治疗放射性肺炎患者对体内细胞及肺纤维化的影响研究[J].中华中医药学刊,2018,36(1):61-63.
[34] 王文龙,卢宏达,林胜友,等.复方苦参注射液对放射性肺损伤的肺保护作用[J].中国实验方剂学杂志,2020, 26(7):42-49.
[1]
梁健1 康文婷1 冯晶2 浦飞飞2 夏平1. 基于“杀虫、补虚”理论探讨中药对脊柱结核免疫调控机制的研究进展 [J]. 中国医药导报, 2023, 20(9): 46-49,57.
[2]
孙宜斌1 朱铭星2 刘跃洋3 赵若玮1 黄鸣清1 程再兴1 郑燕芳1 林彦翔1. 中药抗肝损伤机制的研究进展 [J]. 中国医药导报, 2023, 20(9): 38-40,45.
[3]
李维娜1 缪辉1 王立芳1 董萍1 尹会苏1 李静2 王俏2. 中药熏蒸联合耳穴贴压对2型糖尿病相关干眼患者的临床疗效及炎症反应的影响 [J]. 中国医药导报, 2023, 20(8): 158-162.
[4]
程芳1 胡坤敏1 朱珊2. 活血化瘀类中药抗炎机制研究进展 [J]. 中国医药导报, 2023, 20(8): 46-49,65.
[5]
李文璇1 王月2 王欣悦1 霍启东1 董银萍1 唐生安2 董辉1 李德冠1. 山茱萸提取物对小鼠造血系统辐射损伤的作用研究 [J]. 中国医药导报, 2023, 20(8): 28-33.
[6]
田超1 程梓轩1 郭懿莹2 崔灵珺1 谭煌英3. 国家专利数据库的中药复方治疗胰腺癌用药规律分析 [J]. 中国医药导报, 2023, 20(6): 9-12.
[7]
周夏 钱佳雨 曹建梅. 雷火灸对肛肠疾病患者术后的影响 [J]. 中国医药导报, 2023, 20(6): 145-148.
[8]
韦柳婷1 胡振斌2 高松林1 韦玉珍2 张家增1 张臻1. 基于国家专利数据库分析中药复方治疗非酒精性脂肪性肝病的用药规律 [J]. 中国医药导报, 2023, 20(5): 137-141.
[9]
孙海艳1 赵春生2 佟飞1 贾荣艳1 丁广谦1. 益气补血利水渗湿法治疗中风后尿潴留的临床效果 [J]. 中国医药导报, 2023, 20(5): 160-163.
[10]
张倩 李同侠▲ 黄雪莹 闫璞 石凯峰 王鑫 侯海玲. 中药结肠透析法对慢性肾脏病3~4期湿浊血瘀证患者肠道“微生态”的影响 [J]. 中国医药导报, 2023, 20(5): 155-159.
[11]
吕淑贞1 琚沅红2 徐静雯1 邵琦3 高芷铭1 牟冬梅4. 基于古今医案云平台的中医药治疗痛经用药规律挖掘 [J]. 中国医药导报, 2023, 20(5): 4-8,13.
[12]
李伟男 李永吉 王艳宏 王锐 杨志欣 管庆霞 冯宇飞 李秀岩. 思政教育融入金课标准的中药药剂学汤剂教学的探索与实践 [J]. 中国医药导报, 2023, 20(4): 81-85.
[13]
姜坤 刘军▲ 房勇. 三金汤联合西药对肝胆湿热证梗阻性肾病患者肾功能及氧化应激水平的影响 [J]. 中国医药导报, 2023, 20(3): 75-78.
[14]
李净娅 秋超 张丽萍. 参芪解郁方对产后抑郁大鼠炎症反应的抑制作用 [J]. 中国医药导报, 2023, 20(24): 24-27.
[15]
鲁林1 方虹2. 基于Notch1-Hes1-Prdx蛋白家族通路探究强骨胶囊治疗绝经后骨质疏松的炎症及氧化应激机制 [J]. 中国医药导报, 2023, 20(23): 8-15.